![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4035 | |
A61P 1/16 | |||
A61K 9/20 |
(11) | Number of the document | 3157520 |
(13) | Kind of document | T |
(96) | European patent application number | 15739070.9 |
Date of filing the European patent application | 2015-06-22 | |
(97) | Date of publication of the European application | 2017-04-26 |
(45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/036898 |
Date | 2015-06-22 |
(87) | Number | WO 2015/200177 |
Date | 2015-12-30 |
(30) | Number | Date | Country code |
201462016013 P | 2014-06-23 | US |
(72) |
HOUGH, Douglas, US
STEVENS, Randall, US
|
(73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
(54) | APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY |
APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY |